Naw -- I don't think so. Lets see, a debt-free company with a huge moat, $54 per share earnings and lots of time to let the teapot tempest die down. Think about it, if medical costs become a major issue all they have to do is drop their prices. They would remain profitable, probably sell more units and have more "razor blades" to sell.
I think there is fire underneath the smoke. The daVinci is one costly unit. But it changed the landscape of prostate surgery. That market has shrunk so ISRG has to move into other modalities. Women's health is a good choice. But if ACOG says use conventional, then ISRG is hosed. An OB/GYN who operates with the daVinci on a woman is at risk if there is an adverse event. All surgeries have risk: But if your technical society tells you not to, you will get sued for a higher amount.